Article info

Download PDFPDF
Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method

Authors

  1. Correspondence to Professor Katherine Payne, Manchester Centre for Health Economics, Institute of Population Health, University of Manchester, Jean McFarlane Building, Oxford Road, Manchester M13 9PL, UK; katherine.payne{at}manchester.ac.uk
View Full Text

Citation

Eden M, Payne K, Combs RM, et al
Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method

Publication history

  • Received December 21, 2012
  • Revised March 5, 2013
  • Accepted May 7, 2013
  • First published June 6, 2013.
Online issue publication 
July 10, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.